Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLACSAM-PK
NCT02746276Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Apr 2016
- Primary completion
- Sep 2016
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of ceftriaxone, metronidazole in bacterial infection, sponsored by University of Oxford. Status: unknown.
02
Drugs
ceftriaxonemetronidazole
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02746276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746276.